20-50x ROI, +45% lift in adherence to target, 90% rep adoption, live across US + EU.
Healthcare & Pharma
Compliant execution, inside the systems you trust.
Commercial teams in healthcare and pharma work across a maze of CRM, BI, access, pricing, and patient-support systems - stitching the picture together by hand, inside two regulatory regimes, while payer-side AI rejects claims at scale. Lily consolidates it into one compliant, rep-facing surface: account intelligence, pricing, and access in one place, governed by your rules, with no parallel data plane and no shadow IT.
One compliant surface. No shadow IT. AI that works inside your stack.
8 stops · 2h 10m saved
The problem today
Five systems, two regimes, no single picture.
- Commercial, access, and patient data live in silos - Veeva, SAP, Dynamics, BI, hubs, pricing tools - and reps reconcile them manually.
- The commercial motion spans multiple regulatory regimes and complex specialty-pharmacy hubs.
- New-rep onboarding takes months before anyone is productive.
- Payer-side automation auto-rejects specialty claims at scale, and problems surface too late to act.
- Typical CRM adoption sits at 20-30%, so every commercial investment underdelivers.
How it works
How Lily coordinates compliant commercial execution
- 1
Connects your data
Veeva, SAP, Dynamics, BI, hubs, pricing tools.
- 2
Creates one compliant surface
Account intelligence, pricing, access, next best action.
- 3
Flags risk and opportunity
Payer/claims risk, pricing guidance, target priorities.
- 4
Coordinates the care journey
Field, access, patient-support, and hub teams stay in sync.
- 5
Improves decisions
BD, in-licensing, and commercial actions in hours, not weeks.
The system
Everything you need for compliant execution
What Lily does
One compliant rep surface
Consolidates BI, account intelligence, and pricing into a single rep-facing surface, with payer/claims risk and next best action per target.
Coordinates and speeds decisions
Aligns commercial, access, and patient data so gaps surface early, and stitches market data into one view for BD - HIPAA/BAA-ready by default.
Proof in numbers
- 0%01Rep adoption
- +0%02Adherence to target
- 20-50x03ROI
- First week04Rep onboarding
- 0.0 FTEs05Returned per 25 reps
- US + EU06Live in production
Adoption that sticks
90% rep adoption - far above the 20-30% CRM norm - with new reps productive in their first week, not after months of ramp.
Measured commercial lift
+45% adherence to target and 20-50x ROI on the Kedrion Biopharma deployment, live across both US and EU and returning ~1.5 FTEs per 25 reps.
Integrations
Veeva CRM
SAP
Microsoft Dynamics
Azure
Power BI
Snowflake
Oracle JD Edwards- Specialty-pharmacy hubs
Compliant connectivity
Every connection runs under your governance: BAA, audit trails, no shadow IT.
Built on your systems
Veeva, SAP, Dynamics, Azure, and your BI feed one governed surface, nothing duplicated.
Proof
Proven impact
Pricing automation with supplier price-list ingestion, anomaly detection, and JD Edwards Price Master writeback; supporting a $75-100M cost-savings target.
Email routing/classification + PO/quote automation with EDI 855/856 and phone intake; duplicate POs cut from ~2,500 to ~100.
